Filing Details

Accession Number:
0000902664-19-002561
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-05-30 17:20:20
Reporting Period:
2019-05-28
Accepted Time:
2019-05-30 17:20:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
316253 Enzo Biochem Inc ENZ Services-Medical Laboratories (8071) 132866202
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1233571 J Raymond Harbert 2100 Third Avenue North
Suite 600
Birmingham AL 35203
No No Yes No
1259933 Harbert Management Corp 2100 Third Avenue North
Suite 600
Birmingham AL 35203
No No Yes No
1616659 Harbert Fund Advisors, Inc. 2100 Third Avenue North
Suite 600
Birmingham AL 35203
No No Yes No
1626127 Harbert Discovery Fund, Lp Harbert Discovery Fund Gp, Llc
2100 Third Avenue North, Suite 600
Birmingham AL 35203
No No Yes No
1642336 F. John Bryant C/O Harbert Management Corporation
2100 Third Avenue North, Suite 600
Birmingham AL 35203
No No Yes No
1642389 Kenan Lucas C/O Harbert Management Corporation
2100 Third Avenue North, Suite 600
Birmingham AL 35203
No No Yes No
1642538 Harbert Discovery Fund Gp, Llc 2100 Third Avenue North
Suite 600
Birmingham AL 35203
No No Yes No
1771491 Harbert Discovery Co-Investment Fund I, Lp 2100 Third Avenue North
Suite 600
Birmingham AL 35203
No No Yes No
1771499 Harbert Discovery Co-Investment Fund I Gp, Llc 2100 Third Avenue North
Suite 600
Birmingham AL 35203
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.01 Par Value ("Common Stock") Acquisiton 2019-05-28 50,000 $3.10 5,117,219 No 4 P Indirect See footnote
Common Stock Acquisiton 2019-05-28 13,677 $3.06 5,130,896 No 4 P Indirect See footnote
Common Stock Acquisiton 2019-05-29 19,050 $3.08 5,149,946 No 4 P Indirect See footnote
Common Stock Acquisiton 2019-05-30 19,391 $3.07 5,169,337 No 4 P Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See footnote
No 4 P Indirect See footnote
No 4 P Indirect See footnote
No 4 P Indirect See footnote
Footnotes
  1. The securities reported herein are held by Harbert Discovery Fund, LP (the "Discovery Fund") and Harbert Discovery Co-Investment Fund I, LP (the "Discovery Co-Investment Fund" and together with the Discovery Fund, the "Funds"). Harbert Discovery Fund GP, LLC ( the "Discovery Fund GP") is the general partner of the Discovery Fund, and Harbert Discovery Co-Investment Fund I GP, LLC is the general partner of the Discovery Co-Investment Fund (and together with Harbert Discovery Fund GP, the "Fund GPs"). Harbert Fund Advisors, Inc. is the investment adviser to the Funds. Harbert Management Corporation ("HMC") is the managing member of the Fund GPs. Jack Bryant is a Senior Advisor to the Discovery Fund, and a Vice President and Senior Managing Director of HMC. Kenan Lucas is the managing director and portfolio manager of the Funds. Raymond Harbert is the controlling shareholder, Chairman and Chief Executive Officer of HMC.